(1S,3R)-3-Ethyl-cyclopentanol | 87759-47-5

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: (1S,3R)-3-Ethyl-cyclopentanol
• 英文别名: (1S,3R)-3-ethylcyclopentan-1-ol
• CAS: 87759-47-5
• 化学式: C₇H₁₄O
• 分子量: 114.188
• InChiKey: CRHZGBUSTWVQAQ-RQJHMYQMSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  8
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  甲氧基-三氟甲基苯 、 (1S,3R)-3-Ethyl-cyclopentanol 在 sodium tetrahydroborate 、 1,4-dihydronicotinamide adenine dinucleotide 、 horse liver alcohol dehydrogenase 、 (±)-α-甲氧基-α-(三氟甲基)苯乙酸 作用下， 生成 (R)-3,3,3-Trifluoro-2-methoxy-2-phenyl-propionic acid (1R,3R)-3-ethyl-cyclopentyl ester 、 (R)-3,3,3-Trifluoro-2-methoxy-2-phenyl-propionic acid (1R,3S)-3-ethyl-cyclopentyl ester 、 (R)-3,3,3-Trifluoro-2-methoxy-2-phenyl-propionic acid (1S,3R)-3-ethyl-cyclopentyl ester 、 (R)-3,3,3-Trifluoro-2-methoxy-2-phenyl-propionic acid (1S,3S)-3-ethyl-cyclopentyl ester
  参考文献：
  名称：

  Use of shift reagent with MTPA derivatives in19F NMR spectrocopy: IV—Determination of enantiomeric composition for a variety of secondary cycloalkanols. A survey

  摘要：

  AbstractChiral secondary cycloalkanols (monocyclic alcohols) are derivatized to the corresponding (R)‐α‐methoxy‐α‐trifluoromethyl‐α‐phenylacetic acid [(R)‐MTPA] esters and analysed by 19F NMR in the presence of tris(6,6,7,7,8,8,8‐heptafluoro‐2,2‐dimethyl‐3,5‐octanedionato) europium(III) [Eu(fod)3]. Using this method the enantiomeric composition can be measured for several cyclopentanols, cyclohexanols and cycloheptanols, with a variety of substitution patterns. It is shown that a mixture of four stereoisomeric cycloalkanols, such as cis and trans disubstituted alcohols, can be analysed simultaneously.

  DOI：

  10.1002/omr.1270210609
• 作为产物：
  描述：

  3-丁基-环戊酮 在 1,4-dihydronicotinamide adenine dinucleotide 、 horse liver alcohol dehydrogenase 作用下， 以 乙醇 为溶剂， 生成 (1S,3R)-3-Ethyl-cyclopentanol 、 (1R,3S)-3-n-butylcyclopentanol
  参考文献：
  名称：

  Use of shift reagent with MTPA derivatives in19F NMR spectrocopy: IV—Determination of enantiomeric composition for a variety of secondary cycloalkanols. A survey

  摘要：

  AbstractChiral secondary cycloalkanols (monocyclic alcohols) are derivatized to the corresponding (R)‐α‐methoxy‐α‐trifluoromethyl‐α‐phenylacetic acid [(R)‐MTPA] esters and analysed by 19F NMR in the presence of tris(6,6,7,7,8,8,8‐heptafluoro‐2,2‐dimethyl‐3,5‐octanedionato) europium(III) [Eu(fod)3]. Using this method the enantiomeric composition can be measured for several cyclopentanols, cyclohexanols and cycloheptanols, with a variety of substitution patterns. It is shown that a mixture of four stereoisomeric cycloalkanols, such as cis and trans disubstituted alcohols, can be analysed simultaneously.

  DOI：

  10.1002/omr.1270210609

文献信息

• Hepatitis C Virus Inhibitors
  申请人：Belema Makonen

  公开号：US20110286961A1

  公开（公告）日：2011-11-24

  The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

  本公开涉及化合物、组合物和治疗丙型肝炎病毒（HCV）感染的方法。还公开了含有这些化合物的制药组合物以及使用这些化合物治疗HCV感染的方法。
• [EN] 2, 8-DIAZASPIRO [4.5] DECANE COMPOUNDS<br/>[FR] COMPOSÉS 2,8-DIAZASPIRO[4.5]DÉCANES
  申请人：GENENTECH INC

  公开号：WO2022253341A1

  公开（公告）日：2022-12-08

  Disclosed are 2, 8-diazaspiro [4.5] decane compounds, including (pyrido [3, 4-d] pyrimidin-4-yl) -2, 8-diazaspiro [4.5] decane compounds, (2, 6-naphthyridin-1-yl) -2, 8-diazaspiro [4.5] decane compounds, and (1, 7-naphthyridin-4-yl) -2, 8-diazaspiro [4.5] decane compounds, that are inhibitors of LATS1/2, compositions containing these compounds, and methods for inhibiting LATS1/2 activity.

  本发明涉及2,8-二氮杂螺[4.5]癸烷化合物，包括(吡啶并[3,4-d]嘧啶-4-基)-2,8-二氮杂螺[4.5]癸烷化合物，(2,6-萘啶基)-2,8-二氮杂螺[4.5]癸烷化合物，以及(1,7-萘啶基-4-基)-2,8-二氮杂螺[4.5]癸烷化合物，它们是LATS1/2的抑制剂，以及含有这些化合物的组合物和抑制LATS1/2活性的方法。
• [EN] HETEROCYCLIC CETP INHIBITORS<br/>[FR] INHIBITEURS DE CETP HETEROCYCLIQUES
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2007062314A2

  公开（公告）日：2007-05-31

  [EN] Compounds of formula Ia and Ib wherein A, B, C and R₁ are described herein.
  [FR] La présente invention concerne des composés de formules Ia et Ib dans lesquelles A, B, C et R₁ ont les correspondances indiquées dans l'invention.
• [EN] METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-LH-PYRAZOL-L-YL)-3- CYCLOPENTYLPROPANENITRILE<br/>[FR] MÉTABOLITES DE L'INHIBITEUR DE JANUS KINASE (R)-3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE
  申请人：INCYTE CORP

  公开号：WO2008157207A2

  公开（公告）日：2008-12-24

  [EN] The present invention provides active metablites of 3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.
  [FR] L'invention concerne des métabolites actifs de 3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile qui modulent l'activité de Janus kinases et sont utiles dans le traitement des maladies relatives à l'activité de Janus kinases comprenant, par exemple, des maladies immunologiques, des affections cutanées, des troubles prolifératifs de myéloïde, des cancers, et d'autres maladies.